Finance

Lists
VENUSREM:NSE
Venus Remedies Ltd
₹1,539.00
-4.02%
(-64.40) 1D
Jul 30, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for VENUSREM...
Open
₹1,603.40
High
₹1,603.40
Low
₹1,526.20
Mkt. cap
20.88B
Avg. vol.
59.65K
Volume
31.89K
Dividend
0.65%
Quarterly dividend
₹2.50
Ex-dividend date
Aug 7, 2026
P/E ratio
17.71
52-wk high
₹2,044.30
52-wk low
₹424.00
EPS
₹86.91
Shares outstanding
12.34M
No. of employees
1K
Open
₹1,603.40
High
₹1,603.40
Low
₹1,526.20
Mkt. cap
20.88B
Avg. vol.
59.65K
Volume
31.89K
Dividend
0.65%
Quarterly dividend
₹2.50
Ex-dividend date
Aug 7, 2026
P/E ratio
17.71
52-wk high
₹2,044.30
52-wk low
₹424.00
EPS
₹86.91
Shares outstanding
12.34M
No. of employees
1K
News stories
From sources across the web
About Venus Remedies Ltd
CEOSaransh Chaudhary
Employees1.47K
Founded1989
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.93B
1.80B
2.59B
1.79B
Cost of goods sold
1.07B
862.50M
1.22B
842.80M
Cost of revenue
1.07B
862.50M
1.22B
842.80M
Research and development expenses
43.50M
47.30M
51.03M
46.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
501.30M
517.60M
693.21M
557.20M
Operating expense
606.50M
630.50M
788.52M
671.60M
Total operating expenses
1.68B
1.49B
2.00B
1.51B
Operating income
247.90M
309.60M
589.89M
274.20M
Other non operating income
17.10M
25.20M
-54.65M
26.20M
EBT including unusual items
264.90M
334.70M
615.93M
300.40M
EBT excluding unusual items
264.90M
334.70M
556.56M
300.40M
Income tax expense
63.60M
78.90M
141.14M
70.70M
Effective tax rate
24.01%
23.57%
22.92%
23.54%
Other operating expenses
-
-
-23.33M
-
Net income
201.30M
255.80M
474.79M
229.70M
Net profit margin
10.44%
14.19%
18.30%
12.84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
21.39M
-
Interest expense
-100.00K
-100.00K
-67.00K
-
Net interest expenses
-100.00K
-100.00K
21.32M
-
Depreciation and amortization charges
61.70M
65.60M
67.61M
67.70M
EBITDA
309.65M
358.59M
631.04M
338.38M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps